Archives

by in
Entry Author Date Location
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Boston and Cambridge Renew Rivalry in Startup Real Estate 04/13/12 Boston
New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures 04/09/12 Boston
SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals 04/05/12 San Diego
Xconomy Boston’s Top 20 Stories of Q1: Editor’s Picks 04/02/12 Boston
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
New England’s Emerging Biotech Stars: The Agenda 03/08/12 Boston
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News 02/17/12 Boston
Energy Points, Biogen, Navinet, & More Boston Dealmakers 02/15/12 Boston
Biogen Idec Lets Stromedix Do The Hard Part 02/14/12 Boston
Biogen Buys Stromedix for $75M, Regaining Fibrosis Drug 02/14/12 Boston
Why Biogen Idec Got Out of the Corporate VC Business 01/27/12 Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event 01/26/12 Boston
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More 01/06/12 San Diego
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment 01/04/12 San Diego
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011 12/28/11 Boston
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles 12/23/11 Seattle
Momenta, Baxter Team Up on Biosimilars 12/23/11 Boston
Boston’s Women in Bio Aims to Fuel STEM Curiosity In Middle Schoolers 12/23/11 Boston
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers 12/09/11 Boston
The Genetics Institute Impact: Agenda for Xconomy’s Big Event Dec. 14 12/08/11 Boston
Biogen Idec Boosts Biogenerics Strategy With $300M Samsung Joint Venture 12/06/11 Boston
Seattle Genetics Sees Case of PML, Causing Market Twitch 12/01/11 Seattle
Today’s Xconomy Report: Biogen Idec Meets Goals in Clinical Trial, iRobot Layoffs, $1M Awarded by MassChallenge, and Bay State Venture Capital Earnings 10/28/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
Page 2 of 15 « previous page · next page »